Clinical Trial Update: A Pilot Study to Explore the Safety and Tolerability of Galantamine HBr in the Treatment of Pick Complex/Frontotemporal Dementia [Phase 2]

View source ↗

Summary

This Phase 2 pilot trial evaluated the safety and tolerability of galantamine hydrobromide in Frontotemporal dementia and Pick's disease. The study has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Frontotemporal Dementia
• Pick Disease

Drugs mentioned

• GALANTAMINE HYDROBROMIDE (GALANTAMINE HYDROBROMIDE)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Frontotemporal Dementia, Pick Complex | Phase 2 | Status: COMPLETED